Analgesic Efficacy of Testosterone Replacement in Hypogonadal Opioid-Treated Chronic Pain Patients: A Pilot Study.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00398034|
Recruitment Status : Unknown
Verified November 2006 by James J. Peters Veterans Affairs Medical Center.
Recruitment status was: Recruiting
First Posted : November 10, 2006
Last Update Posted : November 10, 2006
|Condition or disease||Intervention/treatment||Phase|
|Pain Hypogonadism||Drug: Testosterone Gel||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||62 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Analgesic Efficacy of Testosterone Replacement in Hypogonadal Opioid-Treated Chronic Pain Patients: A Pilot Study.|
|Study Start Date :||November 2006|
|Study Completion Date :||October 2008|
- • To determine if testosterone replacement can improve pain control in opioid-treated, hypogonadal men with chronic pain.
- In opioid-treated, hypogonadal men with chronic pain, to determine whether testosterone replacement therapy (TRT) will:
- reduce the opioid requirement.
- improve fatigue
- improve depression
- improve sexual function.
- Improve cognition
- To determine the proportion of responders to the analgesic effects of TRT
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00398034
|Contact: David AN Siegel, M.D.||firstname.lastname@example.org|
|United States, New York|
|James J. Peters VAMC||Recruiting|
|Bronx, New York, United States, 10468|
|Contact: David AN Siegel, M.D. 212-433-0606 email@example.com|
|Principal Investigator: David AN Siegel, M.D.|
|Sub-Investigator: Christopher Cardoza, M.D.|
|Sub-Investigator: William Bauman, M.D.|
|Sub-Investigator: Ann Spungen, Ed.D|
|Principal Investigator:||David AN Siegel, M.D.||James J. Peters VAMC|